Literature DB >> 26483768

Lassa virus isolates from Mali and the Ivory Coast represent an emerging fifth lineage.

John T Manning1, Naomi Forrester1, Slobodan Paessler1.   

Abstract

Previous imported cases of Lassa fever (LF) into the United Kingdom from the Ivory Coast and Mali, as well as the detection of Lassa virus (LASV) among the Mastomys natalensis population within Mali has led to the suggestion that the endemic area for LF is expanding. Initial phylogenetic analyses arrange isolates from Mali and the Ivory Coast separately from the classical lineage IV isolates taken from Sierra Leone, Guinea, and Liberia. The availability of full genome sequences continues to increase, allowing for a more complete phylogenetic comparison of the isolates from Mali and the Ivory Coast to the other existing isolates. In this study, we utilized a Bayesian approach to infer the demographic histories of each LASV isolate for which the full sequence was available. Our results indicate that the isolates from Mali and the Ivory Coast group separately from the isolates of lineage IV, comprising a distinct fifth lineage. The split between lineages IV and V is estimated to have occurred around 200-300 years ago, which coincides with the colonial period of West Africa.

Entities:  

Keywords:  Lassa fever; Lassa virus; genetic diversity; lineage; phylogenetics

Year:  2015        PMID： 26483768      PMCID： PMC4589679          DOI： 10.3389/fmicb.2015.01037

Source DB:  PubMed          Journal:  Front Microbiol        ISSN： 1664-302X            Impact factor:   5.640


Introduction

Lassa virus (LASV) is the causative agent of Lassa fever (LF), a potentially fatal disease that infects as many as 100,000 people annually in endemic areas. Since the discovery of the virus in 1969, the endemic area for LASV has been mapped to the West African countries of Nigeria, Sierra Leone, Guinea, and Liberia (Ogbu et al., 2007). The primary natural host, Mastomys natalensis, is distributed throughout West Africa despite the constricted endemic area of LF, and infected rodents are distributed focally within the endemic area (Demby et al., 2001; Lecompte et al., 2006). However, recent cases of LF within the West African countries of Mali and the Ivory Coast suggest that the endemic area is expanding (Atkin et al., 2009; Sogoba et al., 2012). The virus genome consists of an L and S segment, which encode the RNA-dependent RNA polymerase (LP), matrix (Z) protein, nucleoprotein (NP), and the glycoprotein precursor (GPC). Phylogenetic analyses of either partial or full-length LASV protein sequences have revealed that four lineages exist among LASV isolates. The four lineages correlate strongly with the geographic point of origin for the respective isolates (Bowen et al., 2000). While each lineage can be distinctly delineated from one another in phylogenetic analyses of each full-length gene (with the exception of the small Z protein), there is some variability in the relationships between individual lineages for each gene (Ehichioya et al., 2011). With full-length LASV sequences becoming more readily available, more extensive phylogenetic analyses utilizing full-length genes over a longer time frame can be performed, allowing for more complete characterization of each individual lineage. LASV has been suggested to have arrived in the Sierra Leone region from Nigeria between 150 and 250 years ago due to movement within the colonial period, and the recent emergence of LASV within Mali and the Ivory Coast has been suggested to be caused by movement during the Sierra Leone civil war between 1991 and 2002 (Lalis et al., 2012). The prototypic strain from the Ivory Coast, AV, was reported in 2000 as a case imported into Germany (Gunther et al., 2000). Although cases of LF have been reported in the Ivory Coast and Mali, sequencing data for isolates from these countries has only become available within the last few years (Safronetz et al., 2010, 2013). While the sequence data for these isolates has become readily available, the genetic relationship of these isolates to the classical lineages has not been completely characterized. The purpose of this study was to determine whether a fifth lineage is emerging within Mali and the Ivory Coast using analyses of complete LP, NP, and GPC genes. Using Bayesian analysis, we investigated the relationship of isolates from Mali and the Ivory Coast to all available isolates within the four traditional lineages.

Methods

Sequence alignments

Full-length L and S segments for each available isolate were imported into SeaView 4 (Gouy et al., 2010) from GenBank (Table 1), and nucleotide sequences were aligned as amino acids using MUSCLE (Edgar, 2004), and subsequently converted back to nucleotide sequences in order to maintain third-nucleotide alignment. The resulting alignments were trimmed to include only ORFs for LP, NP, and GPC sequences and exported as nexus files for phylogenetic analysis.
Table 1

Demographic information for each LASV isolate used in the analysis.

IsolateAccession number (L segment)Accession number (S segment)Country of originHostYear of isolation
LASV1016-NIG-2009KM822108.1KM822109.1NigeriaHuman2009
LASV1015-NIG-2009KM822106.1KM822107.1NigeriaHuman2009
LASV1011-NIG-2009KM822104.1KM822105.1NigeriaHuman2009
LASV1008-NIG-2009KM822102.1KM822103.1NigeriaHuman2009
LASV1000-NIG-2009KM822100.1KM822101.1NigeriaHuman2009
LASV993-NIG-2009KM822098.1KM822099.1NigeriaHuman2009
LASV992-NIG-2009KM822096.1KM822097.1NigeriaHuman2009
LASV991-NIG-2009KM822092.1KM822095.1NigeriaHuman2009
LASV989-NIG-2009KM822090.1KM822091.1NigeriaHuman2009
LASV982-NIG-2009KM822087.1KM822088.1NigeriaHuman2009
LASV981-NIG-2009KM822085.1KM822086.1NigeriaHuman2009
LASV979-NIG-2009KM822083.1KM822084.1NigeriaHuman2009
LASV978-NIG-2009KM822081.1KM822082.1NigeriaHuman2009
LASV977-NIG-2009KM822079.1KM822080.1NigeriaHuman2009
LASV976-NIG-2009KM822077.1KM822078.1NigeriaHuman2009
LASV975-NIG-2009KM822075.1KM822076.1NigeriaHuman2009
LASV971-NIG-2009KM822073.1KM822074.1NigeriaHuman2009
LASV967-NIG-2009KM822070.1KM822071.1NigeriaHuman2009
LASV966-NIG-2009KM822068.1KM822069.1NigeriaHuman2009
LASV737-NIG-2009KM822064.1KM822065.1NigeriaHuman2009
LASV719-NIG-2009KM822061.1KM822062.1NigeriaHuman2009
LASV711-NIG-2009KM822058.1KM822059.1NigeriaHuman2009
LASV274-NIG-2010KM822056.1KM822057.1NigeriaHuman2010
LASV271-NIG-2010KM822054.1KM822055.1NigeriaHuman2010
LASV267-NIG-2010KM822052.1KM822053.1NigeriaHuman2010
LASV263-NIG-2011KM822050.1KM822051.1NigeriaHuman2011
LASV256-NIG-2010KM822048.1KM822049.1NigeriaHuman2010
LASV254-NIG-2011KM822046.1KM822047.1NigeriaHuman2011
LASV253-NIG-2011KM822044.1KM822045.1NigeriaHuman2011
LASV251-NIG-2010KM822042.1KM822043.1NigeriaHuman2010
LASV250-NIG-2011KM822040.1KM822041.1NigeriaHuman2011
LASV246-NIG-2010KM822038.1KM822039.1NigeriaHuman2010
LASV245-NIG-2011KM822036.1KM822037.1NigeriaHuman2011
LASV242-NIG-2010KM822034.1KM822035.1NigeriaHuman2010
LASV239-NIG-2010KM822030.1KM822031.1NigeriaHuman2010
LASV237-NIG-2010KM822028.1KM822029.1NigeriaHuman2010
LASV229-NIG-2010KM822026.1KM822027.1NigeriaHuman2010
LASV225-NIG-2010KM822024.1KM822025.1NigeriaHuman2010
LASV221-NIG-2010KM822021.1KM822022.1NigeriaHuman2010
LASV063-NIG-2009KM822019.1KM822020.1NigeriaHuman2009
LASV058-NIG-2008KM822017.1KM822018.1NigeriaHuman2008
LASV056-NIG-2008KM822015.1KM822016.1NigeriaHuman2008
LASV052-NIG-2008KM822013.1KM822014.1NigeriaHuman2008
LASV049-NIG-2009KM822011.1KM822012.1NigeriaHuman2009
LASV046-NIG-2009KM822009.1KM822010.1NigeriaHuman2009
LASV045-NIG-2009KM822007.1KM822008.1NigeriaHuman2009
LASV042-NIG-2009KM822005.1KM822006.1NigeriaHuman2009
LASV006-NIG-2008KM822001.1KM822002.1NigeriaHuman2008
LASV003-NIG-2008KM821999.1KM822000.1NigeriaHuman2008
ISTH2376-NIG-2012KM821997.1KM821998.1Irrua, NigeriaHuman2012
ISTH2358-NIG-2012KM821995.1KM821996.1Irrua, NigeriaHuman2012
ISTH2334-NIG-2012KM821993.1KM821994.1Irrua, NigeriaHuman2012
ISTH2316-NIG-2012KM821991.1KM821992.1Irrua, NigeriaHuman2012
ISTH2312-NIG-2012KM821989.1KM821990.1Irrua, NigeriaHuman2012
ISTH2304-NIG-2012KM821987.1KM821988.1Irrua, NigeriaHuman2012
ISTH2271-NIG-2012KM821985.1KM821986.1Irrua, NigeriaHuman2012
ISTH2217-NIG-2012KM821983.1KM821984.1Irrua, NigeriaHuman2012
ISTH2129-NIG-2012KM821981.1KM821982.1Irrua, NigeriaHuman2012
ISTH2094-NIG-2012KM821978.1KM821979.1Irrua, NigeriaHuman2012
ISTH2066-NIG-2012KM821975.1KM821976.1Irrua, NigeriaHuman2012
ISTH2065-NIG-2012KM821973.1KM821974.1Irrua, NigeriaHuman2012
ISTH2061-NIG-2012KM821970.1KM821971.1Irrua, NigeriaHuman2012
ISTH2046-NIG-2012KM821964.1KM821965.1Irrua, NigeriaHuman2012
ISTH2042-NIG-2012KM821962.1KM821963.1Irrua, NigeriaHuman2012
ISTH2037-NIG-2012KM821960.1KM821961.1Irrua, NigeriaHuman2012
ISTH2031-NIG-2012KM821958.1KM821959.1Irrua, NigeriaHuman2012
ISTH2025-NIG-2012KM821956.1KM821957.1Irrua, NigeriaHuman2012
ISTH2020-NIG-2012KM821954.1KM821955.1Irrua, NigeriaHuman2012
ISTH2016-NIG-2012KM821952.1KM821953.1Irrua, NigeriaHuman2012
ISTH2010-NIG-2012KM821950.1KM821951.1Irrua, NigeriaHuman2012
ISTH1137-NIG-2011KM821948.1KM821949.1Irrua, NigeriaHuman2011
ISTH1129-NIG-2012KM821946.1KM821947.1Irrua, NigeriaHuman2012
ISTH1121-NIG-2012KM821944.1KM821945.1Irrua, NigeriaHuman2012
ISTH1111-NIG-2011KM821942.1KM821943.1Irrua, NigeriaHuman2011
ISTH1107-NIG-2012KM821940.1KM821941.1Irrua, NigeriaHuman2012
ISTH1096-NIG-2012KM821938.1KM821939.1Irrua, NigeriaHuman2012
ISTH1069-NIG-2011KM821936.1KM821937.1Irrua, NigeriaHuman2011
ISTH1064-NIG-2011KM821934.1KM821935.1Irrua, NigeriaHuman2011
ISTH1058-NIG-2011KM821932.1KM821933.1Irrua, NigeriaHuman2011
ISTH1048-NIG-2011KM821930.1KM821931.1Irrua, NigeriaHuman2011
ISTH1038-NIG-2011KM821928.1KM821929.1Irrua, NigeriaHuman2011
ISTH1003-NIG-2011KM821926.1KM821927.1Irrua, NigeriaHuman2011
ISTH0595-NIG-2011KM821923.1KM821924.1Irrua, NigeriaHuman2011
ISTH0531-NIG-2011KM821921.1KM821922.1Irrua, NigeriaHuman2011
ISTH0230-NIG-2011KM821919.1KM821920.1Irrua, NigeriaHuman2011
ISTH0073-NIG-2011KM821917.1KM821918.1Irrua, NigeriaHuman2011
ISTH0047-NIG-2011KM821915.1KM821916.1Irrua, NigeriaHuman2011
ISTH0012-NIG-2011KM821913.1KM821914.1Irrua, NigeriaHuman2011
ISTH0009-NIG-2011KM821911.1KM821912.1Irrua, NigeriaHuman2011
Z0948-SLE-2011KM822131.1KM822132.1Sierra LeoneM. natalensis2011
Z0947-SLE-2011KM822129.1KM822130.1Sierra LeoneM. natalensis2011
LM778-SLE-2012KM822123.1KM822124.1Sierra LeoneM. natalensis2012
LM776-SLE-2012KM822121.1KM822122.1Sierra LeoneM. natalensis2012
LM765-SLE-2012KM822116.1KM822117.1Sierra LeoneM. natalensis2012
LM395-SLE-2009KM822114.1KM822115.1Sierra LeoneM. natalensis2009
LM222-SLE-2010KM822112.1KM822113.1Sierra LeoneM. natalensis2010
LM032-SLE-2010KM822110.1KM822111.1Sierra LeoneM. natalensis2010
G3278-SLE-2013KM821908.1KM821909.1Sierra LeoneHuman2013
G3248-SLE-2013KM821905.1KM821906.1Sierra LeoneHuman2013
G3234-SLE-2013KM821903.1KM821904.1Sierra LeoneHuman2013
G3229-SLE-2013KM821901.1KM821902.1Sierra LeoneHuman2013
G3206-SLE-2013KM821898.1KM821899.1Sierra LeoneHuman2013
G3170-SLE-2013KM821896.1KM821897.1Sierra LeoneHuman2013
G3151-SLE-2013KM821893.1KM821894.1Sierra LeoneHuman2013
G3148-SLE-2013KM821891.1KM821892.1Sierra LeoneHuman2013
G3106-SLE-2013KM821888.1KM821889.1Sierra LeoneHuman2013
G3010-SLE-2013KM821881.1KM821882.1Sierra LeoneHuman2013
G2944-SLE-2012KM821879.1KM821880.1Sierra LeoneHuman2012
G2868-SLE-2012KM821873.1KM821874.1Sierra LeoneHuman2012
G2723-SLE-2012KM821870.1KM821871.1Sierra LeoneHuman2012
G2612-SLE-2012KM821866.1KM821867.1Sierra LeoneHuman2012
G2587-SLE-2012KM821864.1KM821865.1Sierra LeoneHuman2012
G2565-SLE-2012KM821862.1KM821863.1Sierra LeoneHuman2012
G2557-SLE-2012KM821860.1KM821861.1Sierra LeoneHuman2012
G2554-SLE-2012KM821858.1KM821859.1Sierra LeoneHuman2012
G2431-SLE-2012KM821855.1KM821856.1Sierra LeoneHuman2012
G2427-SLE-2012KM821853.1KM821854.1Sierra LeoneHuman2012
G2405-SLE-2012KM821851.1KM821852.1Sierra LeoneHuman2012
G2392-SLE-2012KM821849.1KM821850.1Sierra LeoneHuman2012
G2363-SLE-2012KM821846.1KM821847.1Sierra LeoneHuman2012
G2295-SLE-2012KM821840.1KM821841.1Sierra LeoneHuman2012
G2280-SLE-2012KM821838.1KM821839.1Sierra LeoneHuman2012
G2263-SLE-2012KM821836.1KM821837.1Sierra LeoneHuman2012
G2259-SLE-2012KM821834.1KM821835.1Sierra LeoneHuman2012
G2222-SLE-2011KM821831.1KM821832.1Sierra LeoneHuman2011
G2197-SLE-2011KM821829.1KM821830.1Sierra LeoneHuman2011
G2184-SLE-2011KM821827.1KM821828.1Sierra LeoneHuman2011
G2165-SLE-2011KM821825.1KM821826.1Sierra LeoneHuman2011
G2147-SLE-2011KM821823.1KM821824.1Sierra LeoneHuman2011
G2141-SLE-2011KM821821.1KM821822.1Sierra LeoneHuman2011
G1960-SLE-2011KM821819.1KM821820.1Sierra LeoneHuman2011
G1792-SLE-2011KM821813.1KM821814.1Sierra LeoneHuman2011
G1774-SLE-2011KM821811.1KM821812.1Sierra LeoneHuman2011
G1727-SLE-2011KM821809.1KM821810.1Sierra LeoneHuman2011
G1646-SLE-2011KM821805.1KM821806.1Sierra LeoneHuman2011
G1529-SLE-2011KM821801.1KM821802.1Sierra LeoneHuman2011
G1442-SLE-2011KM821799.1KM821780.1Sierra LeoneHuman2011
G1200-LIB-2010KM821797.1KM821798.1Sierra LeoneHuman2010
G1190-SLE-2010KM821795.1KM821796.1Sierra LeoneHuman2010
G808-SLE-2010KM821791.1KM821792.1Sierra LeoneHuman2010
G771-SLE-2010KM821788.1KM821789.1Sierra LeoneHuman2010
G733-SLE-2010KM821786.1KM821787.1Sierra LeoneHuman2010
G693-SLE-2009KM821784.1KM821785.1Sierra LeoneHuman2009
G692-SLE-2009KM821782.1KM821783.1Sierra LeoneHuman2009
G676-SLE-2009KM821780.1KM821781.1Sierra LeoneHuman2009
G636-SLE-2009KM821778.1KM821779.1Sierra LeoneHuman2009
G610-SLE-2009KM821776.1KM821777.1Sierra LeoneHuman2009
G503-SLE-2009KM821774.1KM821775.1Sierra LeoneHuman2009
G502-SLE-2009KM821772.1KM821773.1Sierra LeoneHuman2009
Nig08-A19GU481073.1GU481074.1Jos, NigeriaHuman2008
Nig08-A18GU481071.1GU481072.1Jos, NigeriaHuman2008
Nig08-04GU481069.1GU481070.1Abakaliki, NigeriaHuman2008
Nig08-A47GU481079.1GU481080.1Irrua, NigeriaHuman2008
Nig08-A41GU481077.1GU481078.1Irrua, NigeriaHuman2008
Nig08-A37GU481075.1GU481076.1Irrua, NigeriaHuman2008
Bamba-R114KF478761.1KF478766.1Bamba, MaliM. natalensis2012
Komina-R16KF478760.1KF478767.1Komina, MaliM. natalensis2012
Soromba-R30KF478763.1KF478769.1Soromba, MaliM. natalensis2012
Soromba-RKF478762.1KF478765.1Soromba, MaliM. natalensis2009
NLAY179172.1AY179173.1Sierra LeoneHuman (Lethal)2000
AVAY179171.1AY179172.1Ghana/Ivory CoastHuman (Lethal)2000
Z148AY628204.1AY628205.1Zorzor, LiberiaHuman (Non-lethal)1981
MacentaAY628200.1AY628201.1LiberiaHuman (Lethal)1984
BA366GU979513.1GU979514.1GuineaM. natalensis2003
JosiahHQ688674.1HQ688672.1Sierra LeoneHuman (Lethal)1976
Pinneo-NIG-1969KM822127.1KM822128.1Lassa, NigeriaHuman (Non-lethal)1969
Demographic information for each LASV isolate used in the analysis.

Phylogenetic analysis

Trees for LP, NP, and GPC were generated in MrBayes (Huelsenbeck and Ronquist, 2001; Ronquist and Huelsenbeck, 2003). The software utilizes a Bayesian Markov chain Monte Carlo (MCMC) algorithm to infer phylogenetic relationships. Parameters were set to utilize the invariant gamma rate of substitution model. Four chains (one hot chain and three cold chains) were utilized, and data was sampled every 100 steps. Each analysis was run for 10,000,000 steps with burn-ins set to 250,000 steps. Data was analyzed using Tracer version 1.6 (http://tree.bio.ed.ac.uk/software/tracer/) to confirm sufficient data sampling for each data set. BEAST trees were generated for LP, NP, and GPC using BEAST (Drummond and Rambaut, 2007; Drummond et al., 2012). BEAST employs a Bayesian MCMC approach to infer demographic histories, evolutionary rates, and dates of divergence from serially (dated) sampled sequence data. Statistical uncertainty in the data is reflected in the 95% highest posterior density (HPD) values. Analyses were performed using the Bayesian Skyline Plot (BSP) model of population growth, which does not use a pre-specified demographic model (Drummond et al., 2005). The uncorrelated lognormal (UCLN) relaxed clock model, which allows rate variation among lineages in the phylogeny to be estimated (Drummond et al., 2006) was used. The MCMC chain was 100 million samples long, thinned to include every 5000th state in the final sample. The program Tracer version 1.6 was used to confirm stationarity. The software TreeAnnotator version 1.7.1 (http://beast.bio.ed.ac.uk/software/TreeAnnotator) was used to summarize the data output from BEAST. The maximum clade credibility (MCC) tree was estimated using mean node heights after discarding the initial 10% of generations.

Results

Bayesian analysis indicates the presence of a fifth LASV lineage

To begin, we first sought to determine whether there was evidence of a fifth lineage among LASV isolates using full-length NP sequences. The analysis that originally described the four classical lineages was based on partial-length NP sequences, but was later confirmed using full-length sequences from LP, NP, and GPC. While all four lineages were easily delineated from one another using full-length sequences, the relationship of each lineage to one another varied between genes (Bowen et al., 2000; Ehichioya et al., 2011). Therefore, in order to completely characterize the relationships of isolates within Mali and the Ivory Coast to the other classical isolates, we aligned the full-length open reading frames for GPC, NP, and LP and conducted a phylogenetic analysis utilizing the Bayesian MCMC approach (MrBayes v3.2.5) for each gene. Analysis of both the NP and GPC genes produced phylogenetic trees (Figure 1) that resemble the traditional grouping of the four lineages, with lineage I (Pinneo) creating the most basal lineage. The hierarchy continues with lineage II, lineage III (Nig08-A18, Nigo8-A19), and lineage IV. In both trees, the isolates from Mali and the Ivory Coast delineate from lineage IV distinctly with strong bootstrap support. However, analysis of full-length LP nucleotide sequences (Figure 1) places lineage II as the most basal lineage, followed by lineage I, lineage III, and lineage IV.
Figure 1

Bayesian analysis of complete LP, NP, and GPC nucleotide sequences. Complete open reading frames were aligned using MUSCLE, and analyzed using the Bayesian MCMC approach. The resulting trees for LP (A), NP (B), and GPC (C) were visualized using FigTree v1.4.2 and rooted using two representative Mopeia virus isolates. To better visualize distinct lineages, several Sierra Leonian, and Nigerian isolates were collapsed. These sections of the trees are provided in Figures S1–S6. Posterior probabilities are represented as node labels for the main clades, with 1 being 100% probability. The isolates are grouped by their respective lineages, as represented by the bars to the right of the trees. The scale represents nucleotide changes per site per year.

Bayesian analysis of complete LP, NP, and GPC nucleotide sequences. Complete open reading frames were aligned using MUSCLE, and analyzed using the Bayesian MCMC approach. The resulting trees for LP (A), NP (B), and GPC (C) were visualized using FigTree v1.4.2 and rooted using two representative Mopeia virus isolates. To better visualize distinct lineages, several Sierra Leonian, and Nigerian isolates were collapsed. These sections of the trees are provided in Figures S1–S6. Posterior probabilities are represented as node labels for the main clades, with 1 being 100% probability. The isolates are grouped by their respective lineages, as represented by the bars to the right of the trees. The scale represents nucleotide changes per site per year. Within lineage IV, the Liberian isolates (Z148, Macenta, 1200LIB10) cluster together in only the LP analysis. The isolate 1200LIB10 however does share a recent common ancestor with Z148 and Macenta in the NP analysis despite being most closely related to the Sierra Leone isolates. Interestingly, the 1200LIB10 isolate clusters within the Sierra Leone isolate clade in the GPC analysis. The Guinea rodent isolate BA366 is basal to the Liberia and Sierra Leone isolates in the NP analysis, but shares a more recent common ancestor with the Sierra Leone strains with respect to Z148 and Macenta in the GPC analysis. Five strains of LASV fell into a different grouping, designated Lineage V, these strains included AV (Ivory Coast/Ghana), BambaR114 (Mali), KominaR16 (Mali) SorombaR (Mali), and SonombaR30 (Mali). These form a single well defined lineage with high posterior probability support. All the isolates from this lineage were isolated from Mali and the Ivory Coast suggesting that this lineage is geographically restricted, maybe due to either geographical barriers or distribution of a distinct haplotype of the rodent host M. natalensis.

The fifth LASV lineage emerged during the colonial period

In order to determine when the lineage emerged, we performed a BEAST analysis using the trees obtained from MrBayes. By providing the year of isolation for each isolate, we were able to approximate the emergence of lineages IV and V from their nearest common ancestor. Analysis of all three complete genes estimates the emergence of lineage V to have occurred roughly 250 years ago (Figure 2), which coincides with movement throughout the region during the colonial period of West Africa. While both S segment genes estimate the most recent common ancestor between lineages IV and V to have existed between 200 and 300 years ago, the estimated range is much larger in the LP analysis (141–416 years ago). The most recent common ancestor of the lineage V group was approximately 114 years ago, with a range of 225–30.
Figure 2

BEAST analysis of complete LP, NP, and GPC nucleotide sequences. Complete open reading frames were aligned using MUSCLE, and analyzed using the Bayesian MCMC approach. The resulting trees for LP (A), NP (B), and GPC (C) were visualized using FigTree v1.4.2 and rooted using two representative Mopeia virus isolates. To better visualize distinct lineages, several Sierra Leonian and Nigerian isolates were collapsed, and these sections of the trees are provided in Figures S7–S12. The node ages, in years, are included on the major nodes, with the 95% confidence ranges displayed in parentheses below the median node ages. The isolates are grouped by their lineages, as represented by the bars to the right of the trees. The reverse axis represents the age, in years, from the most recent isolate.

BEAST analysis of complete LP, NP, and GPC nucleotide sequences. Complete open reading frames were aligned using MUSCLE, and analyzed using the Bayesian MCMC approach. The resulting trees for LP (A), NP (B), and GPC (C) were visualized using FigTree v1.4.2 and rooted using two representative Mopeia virus isolates. To better visualize distinct lineages, several Sierra Leonian and Nigerian isolates were collapsed, and these sections of the trees are provided in Figures S7–S12. The node ages, in years, are included on the major nodes, with the 95% confidence ranges displayed in parentheses below the median node ages. The isolates are grouped by their lineages, as represented by the bars to the right of the trees. The reverse axis represents the age, in years, from the most recent isolate. Movement of the virus from Nigeria to the Mano river region is predicted to have occurred between roughly between 300 – 500 years ago with respect to the S segment genes (Figure 2). However, the range for the LP gene is much larger (190–693 years ago). Western movement of LASV from Nigeria likely occurred during the pre-colonial period of West Africa between the years 1500 and 1700 AD, although the virus appears to have been circulating in Nigeria prior to 1300 AD. Additionally, the most recent common ancestor of LASV and Mopeia virus (MOPV) is estimated to have existed between 0 and 700 AD based on S segment gene analysis (Figure 2). The origin of LASV in the Nigerian region is most likely, but the sampling of LASV is still heavily biased in favor of certain regions and therefore increased sampling is required to fully determine the origins and movements of this virus.

Discussion

This study represents the first phylogenetic analysis of LASV that includes every available isolate from the traditional four lineages, as well as every available isolate from Mali and the Ivory Coast. While the lineage hierarchy for both the GPC and NP supports the results from the original analysis (Bowen et al., 2000), lineage I is not the most basal lineage in the LP analysis. However, this is not strongly supported by the posterior probability suggesting that until more strains are isolated it will be difficult to resolve with the LP gene. It is possible for two closely related arenaviruses to reassort (Lukashevich, 1992). It is possible that a reassortment event occurred between ancestral lineage I and lineage II strains, but as previous studies have not detected any reassortment events among LASV strains (Vieth et al., 2004; Emonet et al., 2006) this seems unlikely. However, the lineage I isolate was not available at the time. Our results indicate that lineage I remains the most basal lineage based on full-length GPC analysis. However, these findings do not support the previous findings by Ehichioya et al., which places lineage II as the most basal lineage for GPC. Evidence of recombination between arenavirus species has been described within the New World arenaviruses (Fulhorst et al., 1999; Weaver et al., 2000), which could explain different groupings between two genes in the same segment. However, no evidence of recombination was detected in their analysis (Ehichioya et al., 2011). It is possible that the different alignment method utilized prior to our analysis contributed to the different outcome. The discrepancy between the GPC gene and the NP and LP genes in the topology of lineage IV is likely due to the additional number of strains belonging to lineage IV in the GPC gene tree. As full genome sequences of these strains become available we would expect these observed differences to be resolved. Analysis of all three full-length genes supports the emergence of a fifth LASV lineage, which appears to have diverged from a common ancestor with lineage IV around 250 years ago. Conflict situations and the resulting human movement have been described to perturb the virus relationship with its peridomestic natural host, M. natalensis. Movement of M. natalensis over large distances, such as transportation by ship or even through movement of refugees during conflicts, can lead to foci of transmission among the local M. natalensis population (Lalis et al., 2012). Emergence of the fifth lineage may have therefore occurred due to human movement during the colonial period. When comparing the AV strain to the Sierra Leone strains, the AV strain is more closely related to the Liberian BA366 strain and the Nigerian lineage III strains. Based on this relationship between the Nigerian isolates and the isolates of lineages IV and V, it appears likely that the virus spread gradually west, establishing focal points of transmission in the Ivory Coast and Mali prior to its arrival in Liberia, Guinea, and Sierra Leone. Although the prediction varies between the three genes, this migration likely occurred during the pre-colonial and colonial periods, possibly arriving in Mali and the Ivory Coast between 300 and 450 years ago and Guinea or Liberia around 250 years ago. This is supported by the substitution rate estimates previously calculated, suggesting that the spread of LASV across West Africa occurred between 300 and 800 years ago (Ehichioya et al., 2011). Andersen et al. recently performed a similar phylogenetic analysis using a large number of complete L segment sequences. Their conclusions were almost identical to our own, indicating a gradual movement of LASV across West Africa (Andersen et al., 2015). In both analyses, the virus is predicted to have arrived in Mali and the Ivory Coast a full century prior to its arrival in Sierra Leone (Figure 3).
Figure 3

Map of LASV movement across West Africa. Based on the phylogenetic data, LASV has gradually spread west, beginning in Eastern Nigeria. Ehichioya et al. has previously illustrated the movement of LASV within Nigeria (Ehichioya et al., 2011). The isolates of lineage V and the BA366 Liberian isolate share a more direct common ancestor with lineage III than the Sierra Leone Isolates share with lineage III isolates. This suggests that the virus was likely present in Mali, the Ivory Coast, and Liberia prior to establishing itself in Sierra Leone. The areas from which the isolates were collected are shaded in gray.

Map of LASV movement across West Africa. Based on the phylogenetic data, LASV has gradually spread west, beginning in Eastern Nigeria. Ehichioya et al. has previously illustrated the movement of LASV within Nigeria (Ehichioya et al., 2011). The isolates of lineage V and the BA366 Liberian isolate share a more direct common ancestor with lineage III than the Sierra Leone Isolates share with lineage III isolates. This suggests that the virus was likely present in Mali, the Ivory Coast, and Liberia prior to establishing itself in Sierra Leone. The areas from which the isolates were collected are shaded in gray. In conclusion, this study reports that a fifth LASV lineage exists within Mali and the Ivory Coast, sharing a sister relationship with the isolates of lineage IV. Despite the apparent presence of the virus within Mali over the last 200 years, it is peculiar that LF cases have only begun to surface within the last decade. The recent emergence of reported cases may be due to the lack of surveillance in the region, particularly in villages with limited access to healthcare. Nevertheless, the presence of a genetically distinct LASV lineage within this region will likely serve to increase the genetic variability in an already diverse virus species. These findings highlight the importance of considering genetic diversity among LASV isolates when developing and testing treatments and vaccine candidates.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
  25 in total

1.  MrBayes 3: Bayesian phylogenetic inference under mixed models.

Authors:  Fredrik Ronquist; John P Huelsenbeck
Journal:  Bioinformatics       Date:  2003-08-12       Impact factor: 6.937

2.  Current molecular epidemiology of Lassa virus in Nigeria.

Authors:  Deborah U Ehichioya; Meike Hass; Beate Becker-Ziaja; Jacqueline Ehimuan; Danny A Asogun; Elisabeth Fichet-Calvet; Katja Kleinsteuber; Michaela Lelke; Jan ter Meulen; George O Akpede; Sunday A Omilabu; Stephan Günther; Stephan Olschläger
Journal:  J Clin Microbiol       Date:  2010-12-29       Impact factor: 5.948

3.  Clinical Sequencing Uncovers Origins and Evolution of Lassa Virus.

Authors:  Kristian G Andersen; B Jesse Shapiro; Christian B Matranga; Rachel Sealfon; Aaron E Lin; Lina M Moses; Onikepe A Folarin; Augustine Goba; Ikponmwonsa Odia; Philomena E Ehiane; Mambu Momoh; Eleina M England; Sarah Winnicki; Luis M Branco; Stephen K Gire; Eric Phelan; Ridhi Tariyal; Ryan Tewhey; Omowunmi Omoniwa; Mohammed Fullah; Richard Fonnie; Mbalu Fonnie; Lansana Kanneh; Simbirie Jalloh; Michael Gbakie; Sidiki Saffa; Kandeh Karbo; Adrianne D Gladden; James Qu; Matthew Stremlau; Mahan Nekoui; Hilary K Finucane; Shervin Tabrizi; Joseph J Vitti; Bruce Birren; Michael Fitzgerald; Caryn McCowan; Andrea Ireland; Aaron M Berlin; James Bochicchio; Barbara Tazon-Vega; Niall J Lennon; Elizabeth M Ryan; Zach Bjornson; Danny A Milner; Amanda K Lukens; Nisha Broodie; Megan Rowland; Megan Heinrich; Marjan Akdag; John S Schieffelin; Danielle Levy; Henry Akpan; Daniel G Bausch; Kathleen Rubins; Joseph B McCormick; Eric S Lander; Stephan Günther; Lisa Hensley; Sylvanus Okogbenin; Stephen F Schaffner; Peter O Okokhere; S Humarr Khan; Donald S Grant; George O Akpede; Danny A Asogun; Andreas Gnirke; Joshua Z Levin; Christian T Happi; Robert F Garry; Pardis C Sabeti
Journal:  Cell       Date:  2015-08-13       Impact factor: 41.582

4.  SeaView version 4: A multiplatform graphical user interface for sequence alignment and phylogenetic tree building.

Authors:  Manolo Gouy; Stéphane Guindon; Olivier Gascuel
Journal:  Mol Biol Evol       Date:  2009-10-23       Impact factor: 16.240

5.  Natural rodent host associations of Guanarito and pirital viruses (Family Arenaviridae) in central Venezuela.

Authors:  C F Fulhorst; M D Bowen; R A Salas; G Duno; A Utrera; T G Ksiazek; N M De Manzione; E De Miller; C Vasquez; C J Peters; R B Tesh
Journal:  Am J Trop Med Hyg       Date:  1999-08       Impact factor: 2.345

Review 6.  Phylogeny and evolution of old world arenaviruses.

Authors:  Sébastien Emonet; Jean-Jacques Lemasson; Jean-Paul Gonzalez; Xavier de Lamballerie; Rémi N Charrel
Journal:  Virology       Date:  2006-02-21       Impact factor: 3.616

7.  Lassa fever in Guinea: II. Distribution and prevalence of Lassa virus infection in small mammals.

Authors:  A H Demby; A Inapogui; K Kargbo; J Koninga; K Kourouma; J Kanu; M Coulibaly; K D Wagoner; T G Ksiazek; C J Peters; P E Rollin; D G Bausch
Journal:  Vector Borne Zoonotic Dis       Date:  2001       Impact factor: 2.133

Review 8.  Lassa fever in West Africa: evidence for an expanded region of endemicity.

Authors:  N Sogoba; H Feldmann; D Safronetz
Journal:  Zoonoses Public Health       Date:  2012-09       Impact factor: 2.702

9.  Relaxed phylogenetics and dating with confidence.

Authors:  Alexei J Drummond; Simon Y W Ho; Matthew J Phillips; Andrew Rambaut
Journal:  PLoS Biol       Date:  2006-03-14       Impact factor: 8.029

10.  Geographic distribution and genetic characterization of Lassa virus in sub-Saharan Mali.

Authors:  David Safronetz; Nafomon Sogoba; Job E Lopez; Ousmane Maiga; Eric Dahlstrom; Marko Zivcec; Friederike Feldmann; Elaine Haddock; Robert J Fischer; Jennifer M Anderson; Vincent J Munster; Luis Branco; Robert Garry; Stephen F Porcella; Tom G Schwan; Heinz Feldmann
Journal:  PLoS Negl Trop Dis       Date:  2013-12-05
View more
  35 in total

1.  Adjuvant formulated virus-like particles expressing native-like forms of the Lassa virus envelope surface glycoprotein are immunogenic and induce antibodies with broadly neutralizing activity.

Authors:  Helena Müller; Sarah Katharina Fehling; Jens Dorna; Richard A Urbanowicz; Lisa Oestereich; Yvonne Krebs; Larissa Kolesnikova; Martin Schauflinger; Verena Krähling; N'Faly Magassouba; Elisabeth Fichet-Calvet; Jonathan K Ball; Andreas Kaufmann; Stefan Bauer; Stephan Becker; Veronika von Messling; Thomas Strecker
Journal:  NPJ Vaccines       Date:  2020-08-04       Impact factor: 7.344

Review 2.  Understanding the cryptic nature of Lassa fever in West Africa.

Authors:  Rory Gibb; Lina M Moses; David W Redding; Kate E Jones
Journal:  Pathog Glob Health       Date:  2017-09-06       Impact factor: 2.894

3.  Temporal analysis of Lassa virus infection and transmission in experimentally infected Mastomys natalensis.

Authors:  David Safronetz; Kyle Rosenke; Kimberley Meade-White; Angela Sloan; Ousmane Maiga; Sidy Bane; Cynthia Martellaro; Dana P Scott; Nafomon Sogoba; Heinz Feldmann
Journal:  PNAS Nexus       Date:  2022-07-13

4.  Quadrivalent VesiculoVax vaccine protects nonhuman primates from viral-induced hemorrhagic fever and death.

Authors:  Robert W Cross; Rong Xu; Demetrius Matassov; Stefan Hamm; Theresa E Latham; Cheryl S Gerardi; Rebecca M Nowak; Joan B Geisbert; Ayuko Ota-Setlik; Krystle N Agans; Amara Luckay; Susan E Witko; Lena Soukieh; Daniel J Deer; Chad E Mire; Heinz Feldmann; Christian Happi; Karla A Fenton; John H Eldridge; Thomas W Geisbert
Journal:  J Clin Invest       Date:  2020-01-02       Impact factor: 14.808

5.  Convergent Structures Illuminate Features for Germline Antibody Binding and Pan-Lassa Virus Neutralization.

Authors:  Kathryn M Hastie; Robert W Cross; Stephanie S Harkins; Michelle A Zandonatti; Anatoliy P Koval; Megan L Heinrich; Megan M Rowland; James E Robinson; Thomas W Geisbert; Robert F Garry; Luis M Branco; Erica Ollmann Saphire
Journal:  Cell       Date:  2019-08-08       Impact factor: 66.850

6.  Ribavirin for treating Lassa fever: A systematic review of pre-clinical studies and implications for human dosing.

Authors:  Alex P Salam; Alexandre Duvignaud; Marie Jaspard; Denis Malvy; Miles Carroll; Joel Tarning; Piero L Olliaro; Peter W Horby
Journal:  PLoS Negl Trop Dis       Date:  2022-03-30

7.  Spatial and temporal evolution of Lassa virus in the natural host population in Upper Guinea.

Authors:  Elisabeth Fichet-Calvet; Stephan Ölschläger; Thomas Strecker; Lamine Koivogui; Beate Becker-Ziaja; Amara Bongo Camara; Barré Soropogui; N'Faly Magassouba; Stephan Günther
Journal:  Sci Rep       Date:  2016-02-25       Impact factor: 4.379

8.  New Lineage of Lassa Virus, Togo, 2016.

Authors:  Shannon L M Whitmer; Thomas Strecker; Daniel Cadar; Hans-Peter Dienes; Kelly Faber; Ketan Patel; Shelley M Brown; William G Davis; John D Klena; Pierre E Rollin; Jonas Schmidt-Chanasit; Elisabeth Fichet-Calvet; Bernd Noack; Petra Emmerich; Toni Rieger; Svenja Wolff; Sarah Katharina Fehling; Markus Eickmann; Jan Philipp Mengel; Tilman Schultze; Torsten Hain; William Ampofo; Kofi Bonney; Juliana Naa Dedei Aryeequaye; Bruce Ribner; Jay B Varkey; Aneesh K Mehta; G Marshall Lyon; Gerrit Kann; Philipp De Leuw; Gundolf Schuettfort; Christoph Stephan; Ulrike Wieland; Jochen W U Fries; Matthias Kochanek; Colleen S Kraft; Timo Wolf; Stuart T Nichol; Stephan Becker; Ute Ströher; Stephan Günther
Journal:  Emerg Infect Dis       Date:  2018-03       Impact factor: 6.883

9.  Field validation of recombinant antigen immunoassays for diagnosis of Lassa fever.

Authors:  Matthew L Boisen; Jessica N Hartnett; Jeffrey G Shaffer; Augustine Goba; Mambu Momoh; John Demby Sandi; Mohamed Fullah; Diana K S Nelson; Duane J Bush; Megan M Rowland; Megan L Heinrich; Anatoliy P Koval; Robert W Cross; Kayla G Barnes; Anna E Lachenauer; Aaron E Lin; Mahan Nekoui; Dylan Kotliar; Sarah M Winnicki; Katherine J Siddle; Michael Gbakie; Mbalu Fonnie; Veronica J Koroma; Lansana Kanneh; Peter C Kulakosky; Kathryn M Hastie; Russell B Wilson; Kristian G Andersen; Onikepe O Folarin; Christian T Happi; Pardis C Sabeti; Thomas W Geisbert; Erica Ollmann Saphire; S Humarr Khan; Donald S Grant; John S Schieffelin; Luis M Branco; Robert F Garry
Journal:  Sci Rep       Date:  2018-04-12       Impact factor: 4.379

10.  Lassa Virus Seroprevalence in Sibirilia Commune, Bougouni District, Southern Mali.

Authors:  Nafomon Sogoba; Kyle Rosenke; Jennifer Adjemian; Sory Ibrahim Diawara; Ousmane Maiga; Moussa Keita; Drissa Konaté; Abdoul Salam Keita; Ibrahim Sissoko; Matt Boisen; Diana Nelson; Darin Oottamasathien; Molly Millett; Robert F Garry; Luis M Branco; Sékou F Traoré; Seydou Doumbia; Heinz Feldmann; David Safronetz
Journal:  Emerg Infect Dis       Date:  2016-04       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.